Immunology & Rheumatology Clinical Trials

Statistical methods in immunology & rheumatology trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All immunology & rheumatology trials

1,062 results

• POGOIndependent statistical analysis of Pediatric Cardiac Output Monitoring Observational Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04465370).Phase NAResults postedn = 89NCT04465370
• Poly-ICLCIndependent statistical analysis of Enhancement by Poly-ICLC During HIV-1 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02071095).Phase 1/2Results postedn = 15NCT02071095
• Pomalidomide for Chronic Graft-versus-Host Disease: Complete Statistical AnalysisIndependent statistical analysis of Pomalidomide for Chronic Graft-versus-Host Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01688466).Phase 2Results postedn = 34NCT01688466
• POPPiIndependent statistical analysis of Improving Uptake and Adherence to HIV Prevention Services With Pre-exposure Prophylaxis (PrEP), HIV Self- Testing and Adherence Support for Very High Risk HIV-negative Young Women Aged 15-24 in…Phase NAResults postedn = 60NCT04030520
• Positive Youth Development in the Metaverse: Complete Statistical AnalysisIndependent statistical analysis of Positive Youth Development in the Metaverse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05858593).Phase NAResults postedn = 32NCT05858593
• Post Market Clinical Follow-Up of the Zimmer Stafit Acetabular System: Complete Statistical AnalysisIndependent statistical analysis of Post Market Clinical Follow-Up of the Zimmer Stafit Acetabular System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04079114).Phase NAResults postedn = 166NCT04079114
• Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert: Complete Statistical AnalysisIndependent statistical analysis of Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01467947).Phase 4Results postedn = 46NCT01467947
• PRACTICEIndependent statistical analysis of Package of Resources for Assisted Contact Tracing: Implementation, Costs, and Effectiveness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 841NCT05343390
• Pramlintide in Adolescents With Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Pramlintide in Adolescents With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00842075).Phase NAResults postedn = 10NCT00842075
• PRE-SURGE1Independent statistical analysis of PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00829829).Phase 3Results postedn = 241NCT00829829
• PrE1003Independent statistical analysis of Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 1/2Results postedn = 63NCT00790842
• PRECISEIndependent statistical analysis of PEAK PlasmaBlade 4.0 Versus Traditional Electrosurgery in Total Knee Replacement.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01081886).Phase NAResults postedn = 24NCT01081886
• PREDICTIndependent statistical analysis of A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 4Results postedn = 736NCT01255761
• PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin: Complete Statistical AnalysisIndependent statistical analysis of PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 3Results postedn = 758NCT00332202
• PrEP ProIndependent statistical analysis of Multi-component Intervention to Train Providers to Promote PrEP for Girls and Women in the Deep South: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 46NCT06487390
• Preventing Sexual Transmission of HIV With Anti-HIV Drugs: Complete Statistical AnalysisIndependent statistical analysis of Preventing Sexual Transmission of HIV With Anti-HIV Drugs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00074581).Phase 3Results postedn = 3,526NCT00074581
• Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 362NCT01278745
• Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.: Complete Statistical AnalysisIndependent statistical analysis of Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.: primary endpoint results,…Phase 3Results postedn = 489NCT00829010
• PRISMIndependent statistical analysis of Efficacy and Safety Study of I10E in Treatment of Patients With CIDP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 3Results postedn = 44NCT02293460
• PRO SoloIndependent statistical analysis of Participant-Reported Outcomes With the Accu-Chek® Solo Micropump System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03478969).Phase NAResults postedn = 181NCT03478969
• Problem-Solving Skills Training to Improve Care for Children With Asthma: Complete Statistical AnalysisIndependent statistical analysis of Problem-Solving Skills Training to Improve Care for Children With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00250588).Phase NAResults postedn = 252NCT00250588
• PROMOTE-PIsIndependent statistical analysis of Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00993031).Phase 3Results postedn = 389NCT00993031
• PRONTO-PumpIndependent statistical analysis of A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes: primary endpoint results, effect estimate with…Phase 3Results postedn = 49NCT03433677
• PRONTO-T1DA detailed statistical analysis of the randomized phase 3 PRONTO-T1D trial of LY900014 in participants with type 1 diabetes, including HbA1c, postprandial glucose, non-inferiority, ANCOVA, mixed-effects modeling, and safety.Phase 3Results postedn = 1,392NCT03214367
• Prophylactic Efficacy of Relenza Against Influenza A and B: Complete Statistical AnalysisIndependent statistical analysis of Prophylactic Efficacy of Relenza Against Influenza A and B: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01156701).Phase NAResults postedn = 171,705NCT01156701
• Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study: Complete Statistical AnalysisIndependent statistical analysis of Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 3Results postedn = 74NCT01360762
• Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202): Complete Statistical AnalysisIndependent statistical analysis of Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 1,860NCT01879072
• Prospective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS): Complete Statistical AnalysisIndependent statistical analysis of Prospective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS): primary endpoint results, effect estimate with confidence interval, sample-size…Phase NAResults postedn = 256NCT04934800
• Prospective Multicenter Post Approval Study of the LPS-Flex Mobile Bearing Knee: Complete Statistical AnalysisIndependent statistical analysis of Prospective Multicenter Post Approval Study of the LPS-Flex Mobile Bearing Knee: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 266NCT00854295
• Prospective Study of the Impact of Insulin Pump Therapy in Young Children With Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Prospective Study of the Impact of Insulin Pump Therapy in Young Children With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 42NCT00727220
• Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 3Results postedn = 254NCT00920582
• PROTEKTIndependent statistical analysis of Kaletra in Combination With Antiretroviral Agents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01076179).Phase NAResults postedn = 502NCT01076179
• Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors: Complete Statistical AnalysisIndependent statistical analysis of Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02950467).Phase 1Results postedn = 30NCT02950467
• PTCLIndependent statistical analysis of Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00865969).Phase 2Results postedn = 129NCT00865969
• PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin’s Lymphoma That Have Not Responded to Standard Treatment: Complete Statistical AnalysisIndependent statistical analysis of PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 1Results postedn = 17NCT01581541
• PUSHIndependent statistical analysis of Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02063880).Phase NAResults postedn = 183NCT02063880
• Qualitative Assessment of Implementing Routine Rapid HIV Testing: Complete Statistical AnalysisIndependent statistical analysis of Qualitative Assessment of Implementing Routine Rapid HIV Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00680862).Phase NAResults postedn = 25NCT00680862
• Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266): Complete Statistical AnalysisIndependent statistical analysis of Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 63NCT01814722
• QUARTZIndependent statistical analysis of QUARTZ, an observational study comparing severe asthma exacerbation rates among cohorts receiving Airsupra or alternative rescue-treatment strategies.n = 8,000NCT07787117
• R-CHOPIndependent statistical analysis of Genes in Predicting Outcome of Patients With DLBCL Treated With Rituximab and Combination Chemotherapy (R-CHOP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 57NCT00450385
• RA-BRANCHIndependent statistical analysis of A Study of Baricitinib in Participants With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04086745).Phase 4Results postedn = 1,050NCT04086745
• RA-MOBILITYComplete statistical analysis of RA-MOBILITY, evaluating sarilumab on top of methotrexate in rheumatoid arthritis, including ACR20 response, HAQ-DI, structural damage, multiplicity, and registry-reported statistical results.Phase 2/3Results postedn = 1,675NCT01061736
• RALLYIndependent statistical analysis of A Phase 3 Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibromyalgia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 514NCT04508621
• Randomised, Double- Blind, Cross-over Efficacy and Safety Comparison of Three Different Doses of Tiotropium Administered Once Daily Versus Placebo in Patients With Moderate Persistent Asthma.: Complete Statistical AnalysisIndependent statistical analysis of Randomised, Double- Blind, Cross-over Efficacy and Safety Comparison of Three Different Doses of Tiotropium Administered Once Daily Versus Placebo in Patients With Moderate Persistent Asthma.: primary endpoint results,…Phase 2Results postedn = 149NCT01233284
• Randomized Controlled Trial of Tranexamic Acid in Total Knee Arthroplasty: Intravenous vs. Topical: Complete Statistical AnalysisIndependent statistical analysis of Randomized Controlled Trial of Tranexamic Acid in Total Knee Arthroplasty: Intravenous vs. Topical: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 4Results postedn = 640NCT01940523
• Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 2Results postedn = 69NCT01059786
• Randomized Trial Comparing Sitagliptin to Placebo in Closed Loop: Complete Statistical AnalysisIndependent statistical analysis of Randomized Trial Comparing Sitagliptin to Placebo in Closed Loop: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02328040).Phase 1Results postedn = 17NCT02328040
• Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 3Results postedn = 1,104NCT03965923
• Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants: Complete Statistical AnalysisIndependent statistical analysis of Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 3Results postedn = 1,714NCT02495168
• RANIAIndependent statistical analysis of Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants…Phase 2Results postedn = 11NCT02116660

← All therapeutic areas